NATCO Pharma Limited
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has NATCO Pharma Limited's balance sheet done over the years? Its assets were worth $69,063,000,000 last year, which is more than in the previous period. 15% of NATCO Pharma Limited’s total assets is currently financed by debt. Its liabilities reached the amount of $10,532,000,000, which means an increase by 25% compared compared to last year.
Debt to Assets
| 2011 | 7073188787 | 3.53B | 50.02% |
|---|---|---|---|
| 2012 | 9027765107 | 4.30B | 47.71% |
| 2015 | 13840449660 | 5.32B | 38.51% |
| 2016 | 18238043248 | 5.20B | 28.54% |
| 2018 | 37151000000 | 6.39B | 17.2% |
| 2019 | 43031000000 | 8.12B | 18.87% |
| 2020 | 45878000000 | 8.03B | 17.51% |
| 2021 | 47919000000 | 6.68B | 13.95% |
| 2022 | 51091000000 | 8.45B | 16.55% |
| 2024 | 69063000000 | 10.53B | 15.25% |
NATCOPHARM.NS Balance Sheet (2011 – 2023)
| 2023 | 2021 | 2020 | 2019 | 2018 | 2017 | 2015 | 2014 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets: | ||||||||||
Cash and cash equivalents | 704M | 1.11B | 258M | 198M | 283M | 217M | 440.65M | 124.41M | 366.31M | 333.28M |
Short term investments | 17.07B | 6.48B | 7.84B | 8.82B | 10.29B | 8.24B | 209.64M | 1.18M | 7.37M | 691.95M |
Net receivables | 11.88B | 6.71B | 4.70B | 6.33B | 6.85B | 6.37B | 2.61B | 1.92B | 0 | 0 |
Inventory | 7.91B | 7.62B | 7.98B | 5.58B | 5.29B | 4.38B | 3.57B | 2.19B | 1.10B | 1.02B |
Other current assets | 6.51B | 3.04B | 2.58B | 8.65B | 750M | 1.91B | 1.01B | 570.58M | 1.65B | 710.86M |
Total current assets | 40.23B | 24.97B | 23.37B | 23.25B | 23.47B | 21.30B | 8.32B | 4.82B | 3.13B | 2.75B |
Non-current assets: | ||||||||||
Property, Plant and Equipment | 24.35B | 23.08B | 22.37B | 20.93B | 18.56B | 14.92B | 9.16B | 7.92B | 4.65B | 3.51B |
Goodwill | 560M | 507M | 0 | 0 | 0 | 0 | 36.93M | 410.26M | 0 | 151.76M |
Intangible assets | 1.37B | 822M | 94M | 88M | 87M | 118M | 52.25M | 49.19M | 162.18M | 16.99M |
Long term investments | 1.39B | -5.65B | -6.25B | -7.99B | -10.09B | -8.16B | -123.78M | 110.86M | 610.50M | -65.92M |
Other non-current assets | 955M | 469M | 285M | -1M | 17M | -59M | 6.34M | 8.31M | 465.10M | 691.95M |
Total non-current assets | 28.82B | 26.11B | 24.54B | 22.62B | 19.55B | 15.84B | 9.91B | 9.01B | 5.89B | 4.31B |
Total assets | 69.06B | 51.09B | 47.91B | 45.87B | 43.03B | 37.15B | 18.23B | 13.84B | 9.02B | 7.07B |
Liabilities | ||||||||||
| Current liabilities: | ||||||||||
Accounts payable | ||||||||||
Deferred revenue | 0 | 877M | 13M | 85M | 66M | 26M | 3.20B | 332.17M | 0 | 0 |
Short term debt | 3.80B | 4.24B | 2.83B | 3.28B | 3.86B | 1.54B | 889M | 2.22B | 816.42M | 0 |
Total current liabilities | 9.72B | 7.10B | 5.25B | 6.85B | 7.28B | 5.92B | 4.92B | 4.13B | 2.56B | 1.08B |
| Non-current liabilities: | ||||||||||
Long term debt | 53M | 80M | 9M | 9M | 0 | 0 | 0 | 1.94B | 1.34B | 2.19B |
Deferred tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 250.86M |
Other non-current liabilities | 749M | 957M | 996M | 902M | 710M | 471M | 276.57M | -747.87M | 111.31M | 0 |
Total non-current liabilities | 804M | 1.35B | 1.42B | 1.17B | 834M | 471M | 276.57M | 1.19B | 1.74B | 2.45B |
Total liabilities | 10.53B | 8.45B | 6.68B | 8.03B | 8.12B | 6.39B | 5.20B | 5.32B | 4.30B | 3.53B |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |